Abivax ABVX
NASDAQ ABVX
$87.58 -2.65 (-2.94%)
As of: Oct 23, 2026 · 3:04 PM EDT

Abivax (ABVX) Net Margin (2024 - 2026)

Updated

Analysis

Abivax (ABVX) Net Margin (2024 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Eli Lilly 1,130.46 Bn 1,099.05 Bn 19.71 Bn 30.88%
2 Johnson & Johnson 635.24 Bn 555.11 Bn 17.30 Bn 0.83%
3 AbbVie 504.85 Bn 477.96 Bn 12.70 Bn 21.27%
4 Merck 358.66 Bn 313.04 Bn 12.21 Bn -8.04%
5 Novartis Ag 290.32 Bn 254.31 Bn 11.24 Bn 22.65%
6 Astrazeneca 265.28 Bn 238.97 Bn 12.86 Bn 16.30%
7 Amgen 237.85 Bn 193.25 Bn 7.24 Bn 23.62%
8 Gilead Sciences 194.96 Bn 169.16 Bn 6.22 Bn -134.51%
9 Pfizer 171.51 Bn 118.16 Bn 10.94 Bn -1.65%
10 Abivax 6.09 Bn 3.73 Bn - -259.01%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -259.01%
Sep 30, 2025 -159.07%
Jun 30, 2025 -867.95%
Mar 31, 2025 -2,430.16%
Dec 31, 2024 -4,541.87%
Sep 30, 2024 -528.13%
Jun 30, 2024 -415.42%
Mar 31, 2024 -633.94%
API Access

Abivax Net Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-margin&ticker=ABVX&period=max&api_key=YOUR_API_KEY